RESUMO
The amino acid L-alanine has been shown to exert long-term cytoprotection by as yet unidentified molecular mechanisms. Using cultured human endothelial cells (ECV 304), the present study investigates the effect of L-alanine on hydrogen peroxide-mediated cytotoxicity and expression of the antioxidant stress proteins, heme oxygenase-1 (HO-1) and ferritin. Pretreatment with L-alanine (0.3-3mM) protected endothelial cells from hydrogen peroxide-dependent cytotoxicity and increased the surviving endothelial cell fraction by 76%. The described protection was associated with a significant induction of heme oxygenase activity and ferritin protein synthesis. A protective effect similar to L-alanine was observed when preincubating the cells with iron-free apoferritin or the antioxidant HO-1 product, bilirubin. The present study demonstrates that L-alanine stimulates expression of the antioxidant defense proteins HO-1 and ferritin in endothelial cells. Increased heme oxygenase activity and ferritin expression improve endothelial dysfunction suggesting an antiatherogenic potential of L-alanine.
Assuntos
Alanina/metabolismo , Antioxidantes/farmacologia , Ferritinas/metabolismo , Heme Oxigenase (Desciclizante)/metabolismo , Alanina/farmacologia , Apoferritinas/farmacologia , Bilirrubina/metabolismo , Sobrevivência Celular , Relação Dose-Resposta a Droga , Células Endoteliais/citologia , Endotélio Vascular/metabolismo , Ferritinas/biossíntese , Ferritinas/farmacologia , Regulação Enzimológica da Expressão Gênica , Heme Oxigenase-1 , Humanos , Peróxido de Hidrogênio/farmacologia , Proteínas de Membrana , Oxidantes/farmacologiaRESUMO
Aspirin is known to exert antioxidant effects by as yet unidentified mechanisms. In cultured endothelial cells derived from human umbilical vein, aspirin (30-300 microM) increased heme oxygenase-1 (HO-1) protein levels in a concentration-dependent fashion up to fivefold over basal levels. HO-1 induction was accompanied by a marked increase in catalytic activity of the enzyme as reflected by enhanced formation of both carbon monoxide and bilirubin. Pretreatment with aspirin or bilirubin at low micromolar concentrations protected endothelial cells from hydrogen peroxide-mediated toxicity. HO-1 induction and endothelial protection by aspirin were not mimicked by indomethacin, another inhibitor of cyclooxygenase. The nitric oxide (NO) synthase blocker L-NAME prevented aspirin-dependent HO-1 induction. These findings demonstrate that aspirin targets HO-1, presumably via NO-dependent pathways. Induction of HO-1 expression and activity may be a novel mechanism by which aspirin prevents cellular injury under inflammatory conditions and in cardiovascular disease.
Assuntos
Antioxidantes/farmacologia , Aspirina/farmacologia , Heme Oxigenase (Desciclizante)/metabolismo , Bilirrubina/química , Bilirrubina/metabolismo , Monóxido de Carbono/química , Monóxido de Carbono/metabolismo , Linhagem Celular , Sobrevivência Celular , Células Cultivadas , Inibidores de Ciclo-Oxigenase/metabolismo , Relação Dose-Resposta a Droga , Endotélio Vascular/citologia , Inibidores Enzimáticos/farmacologia , Heme Oxigenase-1 , Humanos , Peróxido de Hidrogênio/farmacologia , Indometacina/metabolismo , Inflamação , Proteínas de Membrana , NG-Nitroarginina Metil Éster/farmacologia , Oxidantes/metabolismo , Veias Umbilicais/citologiaRESUMO
Pentaerithrityl tetranitrate (PETN) is a long-acting donor of nitric oxide (NO) and has recently been characterized as an antianginal agent that, in contrast with other nitric acid esters, does not induce oxidative stress and is therefore free of tolerance. Moreover, animal experiments have revealed that PETN actively reduces oxygen radical formation in vivoand specifically prevents atherogenesis and endothelial dysfunction. Because heme oxygenase-1 (HO-1) has been described as an antiatherogenic and cytoprotective gene in the endothelium, our aim was to investigate the effect of the active PETN metabolite pentaerithrityl trinitrate (PETriN) on HO-1 expression and catalytic activity in endothelial cells. Endothelial cells derived from human umbilical vein were incubated with PETriN (0.01-1 mM) for 8 hr. PETriN increased HO-1 mRNA and protein levels in a concentration-dependent fashion up to 3-fold over basal levels. Elevation of HO-1 protein was accompanied by a marked increase in catalytic activity of the enzyme as reflected by enhanced formation of both carbon monoxide and the endogenous antioxidant, bilirubin. Pretreatment of endothelial cells with PETriN or bilirubin at low micromolar concentrations protected endothelial cells from hydrogen peroxide-mediated toxicity. HO-1 induction and endothelial protection by PETriN were not mimicked by isosorbide dinitrate, another long-acting nitrate. The present study demonstrates that the active PETN metabolite, PETriN, stimulates mRNA and protein expression as well as enzymatic activity of the antioxidant defense protein, HO-1, in endothelial cells. Increased HO-1 expression and ensuing formation of bilirubin and carbon monoxide may contribute to and explain the specific antioxidant and antiatherogenic actions of PETN.
Assuntos
Bilirrubina/metabolismo , Monóxido de Carbono/metabolismo , Endotélio Vascular/efeitos dos fármacos , Heme Oxigenase (Desciclizante)/metabolismo , Tetranitrato de Pentaeritritol/análogos & derivados , Tetranitrato de Pentaeritritol/farmacologia , Animais , Antioxidantes/metabolismo , Sobrevivência Celular/fisiologia , Células Cultivadas , Endotélio Vascular/citologia , Endotélio Vascular/metabolismo , Heme Oxigenase (Desciclizante)/genética , Heme Oxigenase-1 , Humanos , Dinitrato de Isossorbida/metabolismo , Proteínas de Membrana , Doadores de Óxido Nítrico/metabolismo , S-Nitroso-N-Acetilpenicilamina/metabolismoRESUMO
The organic nitrate pentaerythrityl tetranitrate (PETN) is known to exert long-term antioxidant and antiatherogenic effects by as yet unidentified mechanisms. In cultured endothelial cells derived from human umbilical vein, the active PETN metabolite PETriN (0.01-1 mM) increased heme oxygenase (HO)-1 mRNA and protein levels in a concentration-dependent fashion. HO-1 induction was accompanied by a marked increase in catalytic activity of the enzyme as reflected by enhanced formation of carbon monoxide and bilirubin. Pretreatment with PETriN or bilirubin at low micromolar concentrations protected endothelial cells from hydrogen peroxide-mediated toxicity. HO-1 induction and endothelial protection by PETriN were not mimicked by isosorbide dinitrate, another long-acting nitrate. The present study demonstrates that PETriN stimulates mRNA and protein expression as well as enzymatic activity of the antioxidant defense protein HO-1 in endothelial cells. Increased HO-1 expression and ensuing formation of cytoprotective bilirubin may contribute to and explain the specific antioxidant and antiatherogenic actions of PETN.